Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]

Abstract

Terao T, Ishida A, Kimura T, Yoshida M, Hara T. Neuropsychiatr Dis Treat. 2017;13:1441–1448.On page 1443, Results section, Patient disposition subheading, Figure S1, ‘Excluded from HAM-D analysis setC 69’ should have been ‘Excluded from HAM-D analysis setC 269’.Read the original article